Skip to main navigation
  • About SIGA
  • Products
  • Investors
    • Press Releases
    • Events & Presentations
    • Financial Information
      • SEC Filings
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
      • Contact the Board
      • Contact Audit Committee
    • Stock Information
    • Investor FAQs
    • Investor Contact
  • News
  • Careers
  • Contact

SIGA: Human BioArmor

Providing solutions for unmet needs in health security
  • About SIGA
  • Products
  • Investors
  • News
  • Careers
  • Contact

Press Release Details

Investors
  • Press Releases
  • Events & Presentations
  • Financial Information
    • SEC Filings
  • Corporate Governance
    • Management
    • Board of Directors
    • Committee Composition
    • Contact the Board
    • Contact Audit Committee
  • Stock Information
  • Investor FAQs
  • Investor Contact

SIGA Publishes Article in the Expert Review of Anti-infective Therapy Journal

February 2, 2023 at 12:00 PM EST
SIGA Publishes Article in the Expert Review of Anti-infective Therapy Journal

Latest Press Releases

Mar 02, 2023
SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2022
Feb 23, 2023
SIGA Technologies to Host Business Update Call on March 2nd, 2023 Following Release of Fourth Quarter and Full Year 2022 Financial Results
Feb 02, 2023
SIGA Publishes Article in the Expert Review of Anti-infective Therapy Journal

Shareholder Tools

Print
Email Alerts
RSS News Feeds
Contact IR

SIGA: Human BioArmor

  • Corporate Headquarters
    31 East 62nd Street
    New York, NY 10065
    (212) 672-9100

  • SIGA Development Operations
    4575 SW Research Way, Suite 110
    Corvallis, OR 97333
    (541) 753-2000

  • Privacy Notice

© SIGA Technologies, All Rights Reserved